Table 1.
Clinicopathological analysis of the expression of various tumor markers in surgically resected EOC
| Variables | WT1 | MK | ER | PR | Ki67 | p53 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | ||
| Histology | Serous (n = 75) | 15 | 60 | 16 | 59 | 37 | 38 | 49 | 26 | 35 | 40 | 34 | 41 |
| Others (n = 44) | 20 | 24 | 18 | 26 | 21 | 23 | 27 | 17 | 22 | 22 | 21 | 23 | |
| P | 0.006 | 0.038 | 0.983 | 0.812 | 0.872 | 0.950 | |||||||
| FIGO stage | I/II (n = 51) | 17 | 34 | 14 | 37 | 25 | 26 | 33 | 18 | 24 | 27 | 25 | 26 |
| III/IV (n = 68) | 18 | 50 | 20 | 48 | 33 | 35 | 43 | 25 | 33 | 35 | 30 | 38 | |
| P | 0.542 | 0.977 | 0.895 | 0.978 | 0.979 | 0.730 | |||||||
| Grade | G1/G2 (n = 37) | 16 | 21 | 21 | 16 | 19 | 18 | 22 | 15 | 17 | 20 | 19 | 18 |
| G3 (n = 82) | 19 | 63 | 13 | 69 | 39 | 43 | 54 | 28 | 40 | 42 | 36 | 46 | |
| P | 0.045 | 0.000 | 0.853 | 0.641 | 0.000 | 0.578 | |||||||
| Metastasis | Yes (n = 75) | 20 | 55 | 23 | 52 | 27 | 48 | 45 | 30 | 34 | 41 | 31 | 44 |
| No (n = 44) | 15 | 29 | 11 | 33 | 31 | 13 | 31 | 13 | 23 | 21 | 24 | 20 | |
| P | 0.516 | 0.652 | 0.001 | 0.343 | 0.588 | 0.228 | |||||||
| Chemosensitivity | No (n = 39) | 13 | 26 | 18 | 21 | 17 | 22 | 23 | 16 | 20 | 19 | 20 | 19 |
| Yes (n = 57) | 21 | 36 | 13 | 44 | 22 | 35 | 32 | 25 | 30 | 27 | 28 | 29 | |
| P | 0.892 | 0.029 | 0.781 | 0.948 | 0.938 | 1.000 | |||||||
Legend: ER, estrogen receptor; Ki67, antigen KI-67; MK, midkine; p53, tumor protein 53; PR, progesterone receptor; WT1, Wilms tumor protein; Neg, negative; Pos, positive.